FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

TMO

Thermo Fisher ScientificNYSE · Life Sciences Tools & Services · Health Care
Previous close
648.43
Change
+7.04 / +1.10%
FinDog View
Bullish
52-Week Range
435.27 – 653.40
P/E (TTM)
34.4
Forward P/E
21.8
Based on consensus earnings for the next 12 months
Market Cap
$240B
1M
+10.75%
S&P 500 −2.41% over same period
Volume / Avg Volume
2.9M / 2.0M
1.45× average

Price History

Closing price · USD1M6M1Y5Y
5806006206406602026-082026-082026-092026-092026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 33.21M6M1Y5Y
31323334352026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-23$12.0B6.03 / 5.77−0.71%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-23$11.0B5.44 / 5.29+0.64%Pending
FY2025 Q4
Quarter ended 2025-12
2026-01-29—— / —−2.29%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-22—— / —+0.83%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-23—— / —+1.78%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-23—— / —−1.15%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 65 of its 5-year rangeMid-range
5-year range 24.3 – 40.4 · Median 32.6
Last 4 quarters: $5.0B in buybacks + $662M in dividends, 2.36% of market cap combined
P/E (TTM)
34.4
P/B
4.6
P/S
5.2
Dividend Yield
0.29%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.2% on average on the first trading day after, rising 3 times
Most recent −0.71%
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 7 · $38.9MNet selling $38.9M
  • 08-31Pettiti GianlucaPresident & COOSell$2.5M4,133 shares · 2 trades · Avg price 614.38
  • 08-24CASPER MARC NChairman & CEOSell$0.17M275 shares · 4 trades · Avg price 627.05
  • 08-21CASPER MARC NChairman & CEOSell$6.3M10,000 shares · 5 trades · Avg price 626.92
  • 08-20CASPER MARC NChairman & CEOSell$6.3M10,000 shares · 9 trades · Avg price 629.27
  • 08-19Britt Lisa P.Sr. VP and Chief HR OfficerSell$7.0M11,440 shares · Avg price 613.12
  • 08-11Shafer Michael DExecutive Vice PresidentSell$15.3M25,500 shares · 2 trades · Avg price 600.00
  • 08-07CASPER MARC NChairman & CEOSell$1.4M2,307 shares · 5 trades · Avg price 588.57
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q211.99+10.5%—2.091.741.684.68
FY2026 Q111.01+6.2%—1.861.650.824.43
FY2025 Q412.22+7.2%—2.261.982.995.21
FY2025 Q311.12+4.9%—1.941.621.844.27
FY2025 Q210.86+3.0%—1.831.621.114.28
FY2025 Q110.36+0.2%—1.721.510.363.98
FY2024 Q411.40+4.7%—2.023.162.814.78
FY2024 Q310.60−0.8%—1.841.631.894.25
FY2024 Q210.54−1.6%—1.821.551.664.04
FY2024 Q110.35——1.66—0.903.46
FY2023 Q410.89+2.0%—1.855.963.324.20
FY2023 Q310.69——1.58—1.263.51

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare
ABTAbbott Laboratories$177B33.2+7.8%56.2%−7.26%NeutralCompare